Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Hepatol. Nov 8, 2015; 7(25): 2610-2618
Published online Nov 8, 2015. doi: 10.4254/wjh.v7.i25.2610
Table 2 Characteristics of patients with nonalcoholic fatty liver disease, divided according to nonalcoholic steatohepatitis and steatosis (mean + SD)
ParameterAll patients (n = 235)NASHSteatosisP value
Age (yr)45.3 + 11.945.9 + 12.443.8 + 10.40.2
Gender (male/female)91/14467/10124/430.6
Race (% caucasian)65.164.965.70.1
BMI (kg/m2)37.7 + 11.537 + 10.639.4 + 13.70.17
Hypertension, n (%)114 (48.5)82 + 48.832 + 63.91
Dyslipidemia, n (%)139 (68.8)100 (70.9)39 (63.9)0.3
Metabolic syndrome, n (%)115 + 53.767 (42.7)32 (56.1)0.08
Platelets258 + 73.5247 + 72.1283 + 71.1< 0.01
INR0.996 + 0.1621 + 0.1780.98 + 0.1120.3
Protein (g/dL)7.39 + 0.7627.39 + 0.7337.37 + 0.7140.8
Albumin (g/dL)4.27 + 0.5364.27 + 0.5554.26 + 0.4870.8
AST (U/L)49.8 + 34.554.2 + 36.338.3 + 26.1< 0.01
ALT (U/L)72.6 + 58.578.7 + 63.157 + 40.70.01
Bilirubin (mg/dL)0.668 + 0.4160.71 + 0.4560.567 + 0.2750.01
Alkaline Phosphate96.7 + 61.8100 + 70.988.3 + 28.30.1
Total cholesterol (mg/dL)200 + 47.3202 + 48.6197 + 44.50.5
HDL cholesterol (mg/dL)44.4 + 11.942.7 + 10.748.1 + 13.60.01
Triglycerides (mg/dL)211 + 120220 + 125191 + 1050.18
LDL cholesterol (mg/dL)1119 + 41121 + 41.6114 + 39.80.33
Fasting glucose (mg/dL)126 + 55.5129 + 55.9117 + 53.80.14
HbA1c6.93 + 2.097.12 + 2.196.37 + 1.690.11
Iron (μg/dL)82.6 + 38.783.8 + 40.578.6 + 31.90.52
Total iron binding capacity (μg/dL)322 + 72.3319 + 74.6335 + 63.40.31
Ferritin (ng/mL)258 + 306276 + 324201 + 2320.21
Mallory bodies50 + 21.350 + 29.80< 0.01
CAD67 + 28.950 + 29.917 + 26.20.63
Gastric bypass21 + 8.9414 + 8.337 + 10.40.61
Cirrhosis14 + 5.9614 + 8.3300.01
Steatosis1.92 + 0.8612.1 + 0.831.46 + 0.765< 0.01
Inflammation0.44 + 0.620.625 + 0.6630< 0.01
Fibrosis0.753 + 1.111.05 + 1.210< 0.01
Ballooning0.821 + 0.7121.15 + 0.5750< 0.01
NAS score3.18 + 1.693.86 + 1.451.46 + 0.765< 0.01